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Summary 
Bioassay-guided isolation of antibacterial components of chamomile flower methanol extract 
was performed by OPLC with on-line detection, fractionation combined with sample clean-up 
in-situ in the adsorbent bed after sample application. The antibacterial effect of the fractions 
and the separated compounds remained on the adsorbent layer (do not overrun during OPLC 
separation) was tested with direct bioautography (DB) against the bioluminescent 
Pseudomonas savastanoi pv. maculicola and Vibrio fischeri. The fractions with great 
biologically activity were analysed by SPME-GC-MS and LC-MS/MS and the two active 
uneluted compounds were characterized by OPLC-MS using interface. Mainly essential oil 
components, coumarins, flavonoids, phenolic acids and fatty acids were identified in the 
fractions. 
 
 
1 Introduction 
 
Matricaria recutita L. (syn. Chamomilla recutita L.), Asteraceae, a native plant in Europe has 
been known as a medicinal plant for several thousands of years.  The flower heads are used 
both internally and externally to treat different infections, indigestion and cramps due to its 
antiinflammatory, sedative, analgesic, spasmolytic, antioxidant and antimicrobial properties 
[1-3]. These beneficial effects have been related to different classes of biologically active, 
pharmaceutically interesting substances such as essential oil components, organic acids and 
phenolic components (coumarins, phenolic acids, flavonoids) [4-11]. 
Several in vitro studies showed the antibacterial effect of M. recutita essential oil against 
many bacteria such as Bacillus subtilis, Staphylococcus aureus, Streptococcus mutans and 
Streptococcus salivarius [12-15]. The ethanolic extracts of chamomile exhibit stronger 
antibacterial activity than aqueous ones [3]. The hydroalcoholic (42%) extract exhibited 
antibacterial activity against Gram-positive (Staphylococcus aureus, Streptococcus mutans, 
group B Streptococcus, and Streptococcus salivarius) as well as Gram-negative (Klebsiella 
pneumonia, Escherichia coli, Bacillus megaterium and Leptospira icterohaemorrhagiae) 
bacteria strains [16]. The methanolic extract, enriched in phenolic acids and flavonoids, 
inhibited the growth of S. aureus [14] and had selective inhibitory activity on the growth of 
colon and cervical carcinoma cell lines, without hepatotoxicity [7]. It seems that phenolic 
compounds were responsible for this property. Several studies reported the antibacterial effect 
of individual compounds detected in chamomile [15, 16]. Some components of 50% 
hydroalcoholic chamomile extract that showed inhibitory action against luminescent gene-
tagged Pseudomonas savastanoi pv. maculicola, Bacillus subtilis and Vibrio fischeri have 
been separated, detected and identified in our laboratory using OPLC, TLC/OPLC-direct 
bioautography (DB) and GC-MS or SPME-GC-MS [17, 18]. 
OPLC [19] in mixed operating mode (off-line sample application and on-line detection) can 
be used for fractionation and isolation of separated components from different matrices [18, 
20-22]. The off-line sample application makes sample preparation possible directly in the 
adsorbent layer by washing the uninterested compounds off, using a direction opposite to that 
of the mobile phase that leaves the required components on the start point [22]. With this 
process we can decrease the load of the adsorbent, resulting in better separation, and clearer 
fractions. OPLC coupling with DB [17, 18, 20, 23] enables the bioassay guided isolation of 
bioactive compounds [17, 18, 20].  
To identify the isolated molecules, other off-line hyphenated techniques are needed. In the 
case of chamomile flower extracts, the main volatile components like the sesquiterpenoids ((-
)-alpha-bisabolol, bisabolol-oxides, trans-beta-farnesene, spathulenol) and the polyines (cis- 
and trans-spiroethers), also the coumarin herniarin are easily identifiable by GC-MS or 
SPME-GC-MS [4, 5, 11, 17]. The other chamomile coumarin component umbelliferone can 
be detected also by GC-MS but it has low sensitivity [18]. Other ingredients of chamomile 
extracts as organic acids and phenolic substances are usually characterized by LC-MS(/MS) 
[7-10]. 
The aim of this study was the isolation and characterisation of chamomile components having 
an antibacterial effect against Pseudomonas savastanoi pv. maculicola and/or Vibrio fischeri 
using OPLC, DB, GC-MS, LC-MS/MS and off-line OPLC-MS. 
 
2 Experimental 
 
2.1 Materials 
Aluminum foil-backed normal particle silica gel 60F254 plates (TLC, #5554 from Merck, 
Darmstadt, Germany) were used for TLC separation, as well as for OPLC but in this case the 
layers were sealed on all four edges. All used solvents were analytical grade purchased from 
Reanal (Budapest, Hungary). 
 
2.2 Preparation of plant extracts 
1.5 g of dried (at room temperature) chamomile (Matricaria recutita L.; collected in the end 
of June 2012, in Harta, in the Great Plain, Hungary) flowers were macerated for 48 h with 10 
mL of methanol in a 20 mL screw-capped glass vial. Samples were put into an ultrasonic bath 
for 2x30 s, and filtered (0.45 μm, Nylon).  
Essential oils were obtained by water steam distillation for 3 h, using 10 g of dried, powdered 
plant material using the apparatus prescribed in the seventh Hungarian Pharmacopoeia.  
 
2.3 OPLC and TLC separations 
Methanol extract of chamomile was fractionated by the use of Personal OPLC BS50 system 
(OPLC-NIT, Budapest, Hungary) in mixed operating mode (off-line sample application and 
on-line separation/detection/fraction collection) [19, 22] on TLC layer sealed at all four edges 
and previously washed in the system with 1.5 mL/min (20 mL) acetonitrile-water 85:15 (v/v). 
0.6 mL (12 mg) extract was applied in a 16 cm wide band at 3 cm from the lower edge. In-situ 
clean-up was carried out from the outlet side of the chamber by hexane-chloroform-
acetonitrile, 47.5:47.5:5 (v/v), using the TEST menu at 5 MPa external pressure and 1 
mL/min for 10 minutes.  Without release the external pressure the separation was followed 
with the automatic step-wise gradient separation process using the chamber inlet and the 
following parameters: flow-rate 1 mL/min, rapid eluent flash 10 μL (note: the layer is totally 
wetted), eluent A hexane-chloroform-acetonitrile, 42.5:42.5:15 (v/v) 22 mL, eluent B hexane-
chloroform-acetonitrile, 32.5:32.5:35 (v/v) 22 mL and eluent C acetonitrile-water, 95:5 (v/v) 7 
mL. 
The detection was achieved using an on-line coupled flow-through UV detector at the 
wavelength of 300 nm, respectively. The peaks collected were concentrated by cold air 
stream. The separated components remained on the adsorbent layer (do not overrun during 
OPLC separation) were visualized by UV illuminations (254 and 366 nm), vanillin-sulfuric 
acid reagent and also by direct bioautography. 
The concentrated fractions were chromatographed in unsaturated chamber at room 
temperature on TLC layer with the appropriate above mentioned mixtures of hexane-
chloroform-acetonitrile used for their overrun. The developed plates were dried by a cold air 
stream using a hair-drier (5 min) and the chromatograms were visualised under UV 
illumination at 254 and 365 nm as well as in DB systems. 
 
2.4 In vitro antibacterial test of the fractions 
DB was applied to check the antibacterial activity of the chamomile fractions obtained by 
OPLC separation after UV detection. The in vitro test was performed using two organisms: 
the Gram-negative, luminescence tagged plant pathogenic bacterium Pseudomonas syringae 
pv. maculicola (Psmlux) [24] and the Gram-negative, naturally luminescent marine bacterium 
Vibrio fischeri (Lumistox test strain, Hach-Lange Ltd.).  
Psmlux bacterial cells were grown at 28.5 °C in King’s B broth [25], well aerated in an orbital 
shaker, until they reached the late exponential phase, corresponding to an optical density of 
1.2. V. fischeri strain was grown in the dark shaking at 28.5 °C until it reached an optical 
density of 2.4 at 600 nm, using the following liquid medium (slightly modified recipe of 
NCAIM, Corvinus University, Budapest; ingredients are expressed in g dm–3): pepton 5, yeast 
extract 5, meat extract 6, NaCl 24, MgSO4 3.4, MgCl2×6H2O 5.3, KCl 0.7, and CaCl2 0.1. 
The fractions were developed by TLC, and the dried chromatoplates were dipped into the cell 
suspension for 10 s and immediately put into a closed transparent glass cage, in which the 
bacteria cells receive the appropriate humidity and air. The images of the bioluminescent light 
of the bacterial cells in the bioautogram were taken by a computer-controlled cooled CCD 
camera (IS-4000, Alpha Innotech, San Leandro, USA). The darker areas indicate the lack of 
metabolic activity, which in turn depends on viability. 
 
2.5 Solid phase microextraction (SPME)-GC-MS conditions  
Air-dried chamomile flowers (0.5 g) or 50-200 μL extract were put into vials (20 mL 
headspace) sealed with a silicon/PTFE septum prior to SPME-GC-MS analysis. Sample 
preparation using the static headspace solid phase microextraction (sHS-SPME) technique 
was carried out with a CTC Combi PAL (CTC Analytics AG, Zwingen, Switzerland) 
automatic multipurpose sampler using a 65 μM StableFlex polydimethyl siloxane/divinyl 
benzene (PDMS/DVB) SPME fibre (Supelco, Bellefonte, PA, USA). After an incubation 
period of 5 min at 100ºC, extraction was performed by exposing the fibre to the headspace of 
a 20 mL vial containing the plant material for 10 min at 100ºC. The fibre was then 
immediately transferred to the injector port of the GC-MS, and desorbed for 1 min at 250ºC. 
The SPME fibre was cleaned and conditioned in a Fibre Bake-out Station in pure nitrogen 
atmosphere at 250ºC for 15 min after desorption.  
The analyses were carried out with an Agilent 6890N/5973N GC-MSD (Santa Clara, CA, 
USA) system equipped with an Agilent HP-5MS capillary column (30 m × 250 µm × 0.25 
µm). The GC oven temperature was programmed to increase from 60ºC (3 min isothermal) to 
200ºC at 8ºC/min (2 min isothermal), from 200–230ºC at 10ºC/min (5 min isothermal) and 
finally from 230–250ºC at 10 ºC/min (1 min isothermal). High purity helium was used as 
carrier gas at 1.0 mL/min (37 cm/s) in constant flow mode. The injector temperature was 
250°C and the split ratio was 1:50. The mass selective detector was equipped with a 
quadrupole mass analyser and was operated in electron ionization mode at 70 eV in full scan 
mode (41–500 amu at 3.2 scan/s). The data were evaluated using MSD ChemStation 
D.02.00.275 software (Agilent). The identification of the compounds was carried out by 
comparing retention times and recorded spectra with the data of authentic standards, and the 
NIST 05 library was also consulted. 
 
2.6 LC–MS conditions 
The chromatographic separation was performed on an Agilent 1100 HPLC system equipped 
with G1379A degasser, G1312A binary gradient pump, G1329A autosampler, G1316A 
column thermostat and G1315C diode array detector (DAD) (Agilent Technologies, 
Waldbronn, Germany). Samples were separated on a Zorbax SB C18 (Agilent Technologies, 
Santa Clara, CA, USA) (150 ×3.0 mm I.D., 3.5 µm particle size) column, maintained at 25 ◦C. 
Eluent A was formic acid in water (0.5%, v/v), eluent B was acetonitrile. The following 
gradient program was applied, at a flow rate of 0.4 mL/min: 0 min 90:10 (A:B, v/v), 25 min 
15:85 (A:B, v/v), 26 min 0:100 (A:B, v/v), 29 min 0:100 (A:B, v/v), 30 min 90:10 (A:B, v/v). 
All aqueous solvents were filtered through MF-Millipore (Millipore, Billerica, MA, USA) 
(0.45 µm, mixed cellulose esters) membrane filters. Chromatograms were acquired at 280 nm. 
Injection volume was 5 µL. Before injection all samples were filtered through Sartorius 
(Goettingen, Germany) Minisart RC15 (0.2 µm) syringe filter. 
Mass spectrometric analyses were performed with an Agilent 6410B triple quadrupole 
equipped with an electrospray ionization source (ESI) (Agilent Technologies, Palo Alto, CA, 
USA). ESI conditions were as follows: temperature: 350 ◦C, nebulizer pressure: 45 psi, N2 
drying gas flow rate: 9 L/min, fragmentor voltage: 100 V, capillary voltage: 3500 V, collision 
energy was changed between 5 eV and 50 eV, according to the differences in structures. High 
purity nitrogen was used as collision gas. Full mass scan spectra were recorded in negative 
ionization mode over the range of m/z 50–1000 Da (1 scan/s). The Masshunter B.01.03 
software was used for data acquisition and qualitative analysis. Compounds were tentatively 
characterized by comparison of their retention time, UV and mass spectral data with those 
from the literature. 
 
2.7 Off-line OPLC–MS conditions 
OPLC-MS experiments were performed on an Agilent 1200 HPLC system (Waldbronn, 
Germany) (equipped with a degasser and a binary gradient pump) coupled to a TLC-MS 
interface (Camag, Muttenz, Switzerland) and an Agilent 6410B triple quadrupole equipped 
with an electrospray ionization source (ESI) (Agilent Technologies, Palo Alto, CA, USA).  
Eluent A was trifluoroacetic acid in water (0.1%, v/v), eluent B was acetonitrile. The 
following isocratic eluent system was applied at a flow rate of 1.0 mL/min: 5:95 (A:B, v/v). 
ESI conditions were as follows: temperature: 350 ◦C, nebulizer pressure:40 psi, N2 drying gas 
flow rate: 13 L/min, fragmentor voltage: 135 V, capillary voltage: 4000 V. Collision energy 
was changed between 10 eV and 45 eV, in order to obtain as much structural information as it 
was possible. High purity nitrogen was used as collision gas. Full mass scan spectra were 
recorded in positive ionization mode over the range of m/z 50–1000 Da (1 scan/s). The 
Masshunter B.01.03 software was used for data acquisition and qualitative analysis. 
Compounds were tentatively characterized by comparison of their mass spectral data with 
those from the literature. 
 
3 Results and Discussion 
 
Bioassay-guided isolation of antibacterial chamomile components was based on OPLC 
separation with on-line detection and fractionation combined with previous sample clean-up 
in-situ in the adsorbent bed after sample application. The steps of this procedure are drawn in 
Figure 1. The first step was a partial pre-wetting of the adsorbent layer (Fig. 1, a1) between 
the edge of the layer and the sample application band. The aim is to fill up the “dead” area 
behind the trough, which leads the components to leave the adsorbent layer. With this process 
the zone behind the trough can be prevented against stucking of any components in it, 
otherwise the stucked compounds could be detected continuously during the 
separation/detection/ fraction collection (Fig. 1, b). During the in-situ sample clean-up (2nd 
step, Fig. 1, a2) the development, the mobile phase flow was in the opposite direction, from 
outlet to inlet of the chamber. In this step the load of the adsorbent can be decreased for the 
fractionation (3rd step, Fig. 1, b), what is done in the normal direction of the mobile phase. 
The fraction -1 was collected during the in-situ sample clean-up and 26 fractions (fractions 1-
26) were obtained by a step-wise gradient OPLC separation (Figure 2).  
For bioassay the high throughput TLC/OPLC-DB was applied to monitor the antibacterial 
activity of the fractions and the separated compounds remained on the adsorbent layer. The 
most prospective fractions and compounds were characterized by GC-MS, LC-MS/MS, TLC-
MS. 
According to the SPME-GC-MS results (Table 1), the same volatile components (except the 
chamazulen) were detectable in the essential oil and in the dried chamomile. The methanol 
extracted many essential oil components as well as the coumarin herniarin from the dried 
chamomile flower, which components were collected mainly (during sample clean-up) into 
the fraction -1 and also a small portion of them could be detected in fraction 1. In the fractions 
2-26 there were no components detectable by SPME-GC-MS. The antibacterial chamomile 
components of fraction -1, as the cis-, trans spiroethers, the alpha-bisabolol, the herniarin, and 
the bisabolol oxides (Figure 3) have been investigated and identified in our lab earlier [17, 
18], that is why they were collected mainly into one fraction during the in-situ sample 
preparation process. 
The fractions generally were more active against V. fischeri than Psmlux. In Figure 4 the 
antibacterial effect of the fractions 7-18 is shown against both bacteria. The LC-MS/MS 
analysis of the methanol extract of dried chamomile flower (Figure 5, Table 2) demonstrated 
that the extract contains mainly flavonoids, phenolic acids and fatty acids. In the highlighted 
active fractions there were some flavonoids and phenolic acids tentatively characterized 
(Table 3). Unfortunately no main components were detected in some fractions having great 
antibacterial effect. It seems that for more information further investigations are required, 
which needs bigger amount of sample, therefore for later OPLC fractionation the use of a 
preparative adsorbent layer is preferred. Alternatively, removal of disturbing matrix 
constituents resultant from the adsorbent layer (probably from binding material) or 
employment of other ionization techniques may provide a solution.  
Two of the compounds those remained on the adsorbent layer after fractionation (eluent C) 
were active against both Psmlux and V. fischeri bacteria and were also visible after the use of 
the vanillin-sulphuric acid reagent (Figure 6). The investigation of these two active 
components by off-line OPLC-MS exhibited parent ions at m/z values of 387 and 439, at the 
lower and higher RF, respectively (Figure 7). For their identification further investigations are 
needed. 
 
4 Conclusions 
The applicability of the complex system containing OPLC with on-line detection and 
fractionation, in-situ sample clean-up in the planar layer adsorbent bed, DB, TLC-MS, SPME-
GC-MS, and LC-MS/MS for the bioassay-guided isolation and characterization of bioactive 
compounds from a plant matrix was demonstrated. 
The fractions having antibacterial activity against Psmlux and V. fischeri contained essential 
oil components, coumarins, flavonoids, phenolic acids, and fatty acids, which generally have 
antimicrobial activity [26-28]. 
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Legends: 
 
Figure 1 Schematic drawing of in-situ clean-up (a) and on-line OPLC separation/detection 
fraction collection (b). 
a1, partial pre-wetting of the layer, a2, partial elution of sample 
1, adsorbent layer, 2, sealed edge, 3, eluent inlet trough, 4, eluent outlet trough, 5, band 
shaped sample, 6, front of partial pre-wetting behind the sample, 7, wetted layer, 8, sample 
remained  uneluted after clean-up step, 9, eluted part of sample during the clean-up, I, eluent 
inlet side of the chamber, O, eluent outlet side of the chamber, D, detector, FC, fraction 
collector. 
 
 
Figure 2 OPLC fractionation of methanol chamomile flower extract and the 26 collected 
fractions. Chromatographic conditions see in text, section 2.3. 
 
Figure 3 Detection of the components of fraction -1 collected during the sample preparation. 
A/B – The developed layer (hexane-chloroform-acetonitrile, 47.5:47.5:5, v/v) under UV light 
λ = 254/365 nm; C – Bioautogram using Pseudomonas maculicola (dark spot = inhibition 
zone); D – Bioautogram using Vibrio fischeri (dark spot = inhibition zone). (The components: 
a = cis-spiroether, b = trans-spiroether, c = (–)-alpha-bisabolol, d = herniarin, e = bisabolol 
oxides) 
 
Figure 4 Antibacterial activity of the fractions 7-18 developed by hexane-chloroform-
acetonitrile, 42.5:42.5:15, v/v against Vibrio fischeri and Pseudomonas maculicola. 
 
Figure 5 TIC (A) and UV (B) chromatograms of chamomile methanolic extract. Detection 
wavelength, 280 nm Numbering of peaks refers to data shown in Table 2. Chromatographic 
conditions see in text, section 2.6 LC–MS conditions. 
 
Figure 6 Detection of the components remained on the adsorbent layer after OPLC 
fractionation. A – Bioautogram using Vibrio fischeri (dark spot = inhibition zone); B – 
Bioautogram using Pseudomonas maculicola (dark spot = inhibition zone); C – Visualization 
with vanillin-sulfuric acid reagent. D/E – The developed layers under UV light λ = 254/365 
nm. The arrows show the bands of the two antibacterial components. 
 
Figure 7 TIC chromatograms from OPLC-MS experiments: (A) TIC chromatogram of the two 
compounds remained on the adsorbent layer (after subtraction of the background), (B) TIC 
chromatogram of the background, sampling was performed around the same RF value, as that 
of the two compounds of interest. 
 
Table 1. Identified compounds in chamomile flower and extracts by SPME-GC-MS 
 tR(min) essential oil dried 
flower 
MeOH
extract
OPLC 
Fraction -1 
OPLC 
Fraction 1
Monoterpenes       
p-cymene 7,893 + + - - - 
cineol (eucalyptol) 8,070 + + - - - 
β-ocimene 8,324 + + - - - 
artemisia keton 8,557 + + - - - 
camphor 10,687 + + - - - 
borneol 11,011 + + - - - 
α-terpineol 11,213 + + - - - 
Sesquiterpenes       
β-caryophyllene 15,435 + + - - - 
β-farnesene 15,806 + + + - - 
caryophyllene oxide 16,127 + + + - - 
germacrene D 16,405 + + + - - 
β-selinene 16,549 + + + - - 
α-farnesene 16,641 ++ ++ + - - 
trans-nerolidol 17,539 + + + - - 
spathulenol 17,918 + + + - - 
farnesene-epoxide 18,453 + + + + - 
α-bisabolol oxide B 18,986 + ++ ++ + + 
α-bisabolol 19,381 + ++ ++ + + 
herniarin 20,102 - - + + - 
chamazulene 20,122 + - - - - 
bisabolol oxide A 20,322 + ++ ++ ++ + 
cis en-in-dicycloether 22,262 + + + ++ ++ 
trans en-in-dicycloether 22,537 - + + ++ ++ 
 
Abbreviations: - not detectable, + detectable, ++  large amount 
Table 2. LC–MS/MS data of tentatively identified compounds from chamomile methanolic 
extract 
 
No. tR 
(min) 
λmax 
(nm) 
[M-H]- 
(m/z) 
MS/MS (m/z) Tentative identification a
1 5.8 314 369 161, 133 Umbelliferon hexoside 
2 6.2 292, 315 641 179, 135 Caffeic acid hexoside 
3 6.4 238, 326 353 191, 171 Caffeoylquinic acid 
4 7.4 232, 304 355 193, 149, 134 Ferulic acid hexoside 
isomer 
5 8.3 260, 358 479 317, 207, 163, 113 Myricetin hexoside 
6 9.0 238, 
296, 320 
355 193, 149, 134 Ferulic acid hexoside 
isomer 
7 9.3 256, 370 463 301, 151, 121 Quercetin hexoside 
8 9.5 258, 364 447 285, 175 Luteolin hexoside 
9 10.0 242, 
300, 326 
515 379, 311, 243, 175 Dicaffeoylquinic acid 
isomer 
10 10.2 324 161 133, 105, 89, 77 Umbelliferon 
11 10.4 266, 329 431 363, 295, 269, 211, 159 Apigenin hexoside 
12 10.7 245, 328 515 353, 191, 179, 175, 173 Dicaffeoylquinic acid 
isomer 
13 11.2 242, 315 517 323, 281, 193, 179, 161, 134 Ferrulic acid / Caffeic 
acid derivative 
14 12.1 270, 330 473 269 Apigenin acetylhexoside 
isomer 
355 151, 113 Not identified 15 12.8 266, 
282, 330 473 269 Apigenin acetylhexoside 
isomer 
16 14.6 234, 297 785 665, 545, 243, 145 Hydroxycinnamic acid 
derivative 
329 229, 211, 193, 183, 171 Flavonoid 17 15.1 268, 336 
269 225, 151, 149, 117 Apigenin 
18 16.6 257 441 395, 327, 305, 175 Hydroxybenzoic acid 
derivative 
373 358, 343, 328, 300 Flavonoid 19 18.7 257, 
272, 351 535 520, 491 Flavonoid 
20 20.5 242, 317 545 481, 205, 169 Hydroxycinnamic acid 
derivative 
21 22.0 - 295 221, 159 Fatty acid 
22 23.5 - 295 277, 221, 159 Fatty acid 
23 24.5 - 295 277, 221, 177, 159, 115 Fatty acid 
24 24.9 - 394 226, 196, 180 Not identified 
25 25.5 - 297 249, 197, 183, 141 Fatty acid 
26 27.2 - 295 277, 221, 193, 177, 161, 159 Fatty acid 
27 29.9 - 277 233, 209, 138 Not identified 
a Peak numbers and retention times (tR) refer to chromatograms shown in Fig. 5. 
 
Table 3. LC-MS data and tentative identification of compounds in some highlighted fractions 
obtained from chamomile methanolic extract 
 
Fraction [M-H]- 
(m/z) 
MS/MS (m/z) Tentative identification 
1 393 325, 257 Not idendified 
5 279 - Not idendified 
7 277 233, 209, 138, 97 Not idendified 
11 161 133, 117, 105, 89 Umbelliferon 
353 213, 189, 179, 163, 149, 135 Caffeoylquinic acid 12 
179 135, 91 Caffeic acid 
329 269, 233, 141, 125 Flavonoid 16 
365 231, 174, 161 Not idendified 
17 329 269, 233 Flavonoid 
295 221, 177, 159, 133, 115 Not idendified 
371 325, 309, 289 Hydroxycinnamic acid 
derivative 
20 
473 269 Apigenin acetylhexoside 
21 297 251, 183 Fatty acid 
22 329 299, 293, 285, 271, 257, 243, 235, 199 Flavonoid 
 293 249, 185, 141 Fatty acid 
 295 277, 195 Fatty acid 
 297 279, 183 Fatty acid 
295 277, 221, 177, 161, 159 Fatty acid 23 
293 275, 235, 183 Fatty acid 
269 225, 183, 149, 117 Apigenin 
311 197, 175, 171, 139 Fatty acid 
25 
355 311, 267 Not idendified 
311 293, 275, 201, 185, 171 Fatty acid 
379 311, 293, 193, 171 Fatty acid 
26 
269 225, 183, 149, 117 Apigenin 
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